Meta-Analysis of the Effect of the Use of Computer-Based Systems on the Metabolic Control of Patients with Diabetes Mellitus
Abstract
The purpose of this study was to evaluate, through a meta-analysis study, whether the use of computer-based systems reported in the literature improves the metabolic control of diabetic patients. On the retrieved papers, a set of meta-analysis studies were performed: first the difference of HbA1c between cases and controls at follow-up was evaluated (sign test); then the difference between cases and controls in the total variation of HbA1c from the beginning to the end of the trial was considered (method of effect sizes). The latter methodology was reapplied also on three more homogeneous article subgroups. The sign test was performed on 16 papers: in two of them, the HbA1c level was higher in the intervention group than in the control group at follow-up: it is unlikely that this is a random occurrence (p < 0.01). The method of effect sizes was first applied to 13 papers, as in the others some needed data were missing: the results obtained showed a statistically significant amelioration of metabolic control in the intervention group in comparison to the control group (p < 0.01). A progressive reinforcement of this outcome was obtained on the trial subgroups. Our study supports the hypothesis that the use of computer-based systems can be an effective means of improving metabolic control. The differential benefit obtained in the amelioration of HbA1c does not justify, by itself, the applicability of such systems into clinical practice; additional investigations should be carried out to evaluate the enhancement of other clinical and organizational indicators.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Type 2 diabetes, there were small but statistically significant pooled decreases in HbA1c of −0.6% and a weighted mean difference of −0.2% (95% CI −0.4 to −0.1).
“Type 2 diabetes (−0.6% in HbA1c [39]), (weighted mean difference, −0.2%, 95% C.I. −0.4 to −0.1 [41])”
From The Impact of Telehealthcare on the Quality and Safety of Care: A Systematic Overview (2013) · cites this paper as [39]
In diabetes, one review found benefits to quality of life, self-efficacy and social advantages.
“In diabetes, one review found benefits to quality of life, self-efficacy and social advantages [39], whereas another reported that quality of life was similar in the intervention arm to the usual care arm [41].”
From The Impact of Telehealthcare on the Quality and Safety of Care: A Systematic Overview (2013) · cites this paper as [39]
Cited by
Sorted by citations
Costs and benefits of health information technology.
Shekelle, P. G., Morton, S. C., & Keeler, E. B. (2006) · doi:10.23970/ahrqepcerta132 · Cited by 501 · see citing works
The Impact of Telehealthcare on the Quality and Safety of Care: A Systematic Overview
McLean, S., Sheikh, A., Cresswell, K., Nurmatov, U., Mukherjee, M., Hemmi, A., & Pagliari, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071238 · Cited by 255 · see citing works
Huang, Z., Tao, H., Meng, Q., & Jing, L. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0441 · Cited by 81 · see citing works
Tao, D., & Or, C. K. (2013) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x13479701 · Cited by 68 · see citing works
Egede, L. E., Strom, J. L., Fernandes, J., Knapp, R. G., & Rojugbokan, A. (2011) · Trials · doi:10.1186/1745-6215-12-231 · Cited by 24 · see citing works
- Authors
- Montani, S., Bellazzi, R., Quaglini, S., & D'Annunzio, G.
- Affiliations
- Dipartimento di Informatica e Sistemistica, Università di Pavia, Pavia, Italy; stefania@aim.unipv.it
- University of Pavia (IT)
- I.R.C.C.S. Policlinico S. Matteo, Pavia, Italy
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2001-09
- Volume
- 3
- Issue
- 3
- Pages
- 347-356
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1974626424
- Cited by
- 49
- References
- 0
- Citations by year
- 2021: 2 · 2019: 1 · 2018: 1 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 5 · 2012: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Technology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- computational systems, diabetes mellitus, metabolic control, glycemic control, HbA1c, diabetes technology
- MeSH terms
- Algorithms, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Drug Therapy, Computer-Assisted, Glycated Hemoglobin, Humans, MEDLINE, Treatment Outcome, Telemedicine, Decision Support Systems, Clinical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review